A randomized-controlled trial of SOF/VEL/VOX with or without ribavirin for retreatment of chronic hepatitis C-Reference-Cited by-同舟云学术

A randomized-controlled trial of SOF/VEL/VOX with or without ribavirin for retreatment of chronic hepatitis C

Published:2023-08 Issue:2 Volume:79 Page:314-320
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

El-Kassas Mohamed^ORCID,Emadeldeen Mohammed,Hassany Mohamed,Esmat Gamal,Gomaa Ahmed Ali,El-Raey Fathiya^ORCID,Congly Stephen E.^ORCID,Liu Hongqun,Lee Samuel S.^ORCID

Publisher

Elsevier BV

Subject

Hepatology

Reference22 articles.

1. Natural history of hepatitis C;Lingala;Gastroenterol Clin North Am,2015

2. World health organization (WHO), Hepatitis C fact sheet, Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c [accessed 30 Sep 2022].

3. Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?;Asselah;Liver Int,2018

4. HCV treatment failure in the era of DAAs;Hassany;Adv Treat Hepat C B,2017

5. Retreatment of hepatitis C virus-infected patients with direct-acting antiviral failures;Pawlotsky;Semin Liver Dis,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals;Expert Opinion on Pharmacotherapy;2024-05-02

2. Real‐life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir;Alimentary Pharmacology & Therapeutics;2024-05-02

3. Effectiveness and safety of SOF/VEL containing rescue therapy in treating chronic HCV-GT4 patients previously failed NS5A inhibitors-based DAAs;Egyptian Liver Journal;2024-03-11

4. Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus Retreatment in Difficult-to-treat Patients: A Real-life Observational Study from India;Journal of Clinical and Experimental Hepatology;2024-03

5. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024;Saudi Journal of Gastroenterology;2024-01